Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | TACR1 | P25103 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 3/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23463613 | 0.89 | ALDH1A1 (0.39) | ALDH1A1NPC1PLA2G1BNFKB1CASP3 | |
| SCHEMBL24145272 | 0.84 | PGR (0.36) | ALDH1A1NPC1PLA2G1BNFKB1CASP3 | |
| SCHEMBL24359329 | 0.81 | NPC1 (0.49) | ALDH1A1NPC1PLA2G1BNFKB1CASP3 | |
| SCHEMBL20172771 | 0.81 | PTGES (0.39) | RAB9AKIF11RXRARXRBCYP19A1 | |
| SCHEMBL5552881 | 0.79 | ALDH1A1 (0.48) | ALDH1A1NPC1PLA2G1BNFKB1CASP3 | |
| SCHEMBL5546203 | 0.79 | ALDH1A1 (0.57) | ALDH1A1NPC1PLA2G1BNFKB1CASP3 | |
| SCHEMBL26004981 | 0.79 | ALDH1A1 (0.57) | ALDH1A1NPC1PLA2G1BNFKB1CASP3 | |
| SCHEMBL24145273 | 0.78 | PDK2 (0.42) | ALDH1A1NPC1PLA2G1BNFKB1CASP3 | |
| SCHEMBL6726811 | 0.77 | MEN1 (0.42) | ALDH1A1NPC1RAB9AL3MBTL1PGR | |
| Hydrogen Sulfide SCHEMBL28059716 | 0.77 | ALDH1A1 (0.55) | ALDH1A1NPC1PLA2G1BNFKB1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11678570-B2 | Hole transport material, preparation method thereof, and electroluminescent device | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2023-06-13 | — | — | US | disclosed |
| US-11678570-B2 | Hole transport material, preparation method thereof, and electroluminescent device | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2023-06-13 | — | — | US | disclosed |
| US-20210408389-A1 | HOLE TRANSPORT MATERIAL, PREPARATION METHOD THEREOF, AND ELECTROLUMINESCENT DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11678570-B2 | Hole transport material, preparation method thereof, and electroluminescent device | TSPO, NLRP1, NLRP3 | ALDH1A1 2494/4885NPC1 498/4885PLA2G1B 2890/4885 |
| US-20210408389-A1 | HOLE TRANSPORT MATERIAL, PREPARATION METHOD THEREOF, AND ELECTROLUMINESCENT DEVICE | TSPO, NLRP1, NLRP3 | ALDH1A1 2494/4885NPC1 498/4885PLA2G1B 2890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.